| Authors: |
Radford-Smith DE; Department of Pharmacology, University of Oxford, Oxford, UK., Yates AG; Department of Pharmacology, University of Oxford, Oxford, UK.; Department of Chemistry, University of Oxford, Oxford, UK., Kacerova T; Department of Chemistry, University of Oxford, Oxford, UK., Nylund M; Turku PET Centre, University of Turku, Turku University Hospital and Åbo Akademi University, Turku, Finland.; Clinical Neurosciences University of Turku, Turku, Finland.; Neurocenter, Turku University Hospital, Turku, Finland.; InFLAMES Research Flagship, University of Turku, Turku, Finland., Sucksdorff M; Turku PET Centre, University of Turku, Turku University Hospital and Åbo Akademi University, Turku, Finland.; Clinical Neurosciences University of Turku, Turku, Finland.; Neurocenter, Turku University Hospital, Turku, Finland.; InFLAMES Research Flagship, University of Turku, Turku, Finland., Matilainen M; Turku PET Centre, University of Turku, Turku University Hospital and Åbo Akademi University, Turku, Finland.; Clinical Neurosciences University of Turku, Turku, Finland.; InFLAMES Research Flagship, University of Turku, Turku, Finland., Willemse E; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland., Oechtering J; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland., Maleska Maceski A; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland., Leppert D; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland., Kuhle J; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel, Basel, Switzerland., Probert F; Department of Chemistry, University of Oxford, Oxford, UK., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, UK., Airas L; Turku PET Centre, University of Turku, Turku University Hospital and Åbo Akademi University, Turku, Finland.; Clinical Neurosciences University of Turku, Turku, Finland.; Neurocenter, Turku University Hospital, Turku, Finland.; Multiple Sclerosis Centre, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland. |
